Search
for
Sort by
Research 91–120 of 289
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Dermatological Manifestations of COVID-19: A Brief Review
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- Tracing the cellular origin of cancer
- Stem Cell-Based Hair Cell Regeneration and Therapy in the Inner Ear
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- A Review: Pharmacological Activities of Quinoline Alkaloid of Cinchona sp.
- Androgens in SARS-CoV-2 Coronavirus Infections
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- Untangling the hairy issue of iron deficiency: Making progress
- Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity
- PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Diet and hair loss: effects of nutrient deficiency and supplement use
- Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
- Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium
- Genome Array on Differentially Expressed Genes of Skin Tissue in Cashmere Goat at Early Anagen of Cashmere Growth Cycle Using DNA Microarray
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial